QS Investors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 111 filers reported holding REVANCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.7%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$241,000
-82.7%
9,567
-83.2%
0.00%
-84.2%
Q2 2020$1,395,000
+64.5%
57,089
-0.3%
0.02%
+46.2%
Q1 2020$848,000
-8.0%
57,289
-0.5%
0.01%
+44.4%
Q4 2019$922,000
+15.0%
57,582
-6.6%
0.01%0.0%
Q3 2019$802,000
+0.1%
61,654
-0.1%
0.01%0.0%
Q2 2019$801,000
-19.6%
61,725
-2.3%
0.01%
-18.2%
Q1 2019$996,000
-21.7%
63,1610.0%0.01%
-31.2%
Q4 2018$1,272,000
-19.0%
63,1610.0%0.02%
+6.7%
Q3 2018$1,570,000
-9.5%
63,1610.0%0.02%
-11.8%
Q2 2018$1,734,000
-10.8%
63,161
+0.0%
0.02%
-15.0%
Q1 2018$1,945,000
-20.5%
63,156
-7.7%
0.02%
-13.0%
Q4 2017$2,447,000
+23.6%
68,459
-4.7%
0.02%
+43.8%
Q3 2017$1,980,000
+26.6%
71,866
+21.3%
0.02%
+23.1%
Q2 2017$1,564,000
+323.8%
59,259
+448.7%
0.01%
+225.0%
Q4 2015$369,00010,8000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders